Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata in Dubai mostly affects men, often involves autoimmune disorders, and has high healthcare costs, especially for psychological issues.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Silibinin may help promote hair growth and treat hair loss.

A targetoid hair regrowth pattern indicates recovery in alopecia areata.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.

Sports influence skin condition names and help in diagnosis and treatment.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.